Access Pharmaceutical, Inc. announced today that Jeffrey B. Davis, President & CEO of the company, will be presenting at the Jessup & Lamont 2009 Growth Stock Conference organized by the LifeTech Capital Group on Thursday, July 30, 2009 at 10:45 am EDT. The presentation will be held at the Waldorf Astoria Boca Beach Club in Boca Raton, Florida.
Mr. Davis commented, “We are pleased to have the opportunity to present Access Pharmaceuticals to the large group of institutional and retail investors that attend Jessup’s annual growth stock conference. The conference provides a forum for Access to highlight in many product programs, and specifically the very significant and positive initial results and feedback from the commercial launch of MuGard, our FDA approved treatment for oral mucositis. Initial clinical feedback and experience exceeds our expectations.”
ACCP.OB is currently trading at $2.18, up 14.74%, on above average volume of 40,250 traded shares. With approximately 11.3 million shares of common stock issued and outstanding, the company has a market cap of $25 million. As of March 31, 2009, the company had total assets of $3,624,000 and total liabilities of $15,594,000.
Let us hear your thoughts below: